comparemela.com

Latest Breaking News On - Yissum research - Page 6 : comparemela.com

Die mit CBD beladene Liposomenplattform-Technologie von Innocan Pharma zeigt eine verlängerte Freisetzung bei Großtieren

Die mit CBD beladene Liposomenplattform-Technologie von Innocan Pharma zeigt eine verlängerte Freisetzung bei Großtieren
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Innocan Pharma Corporation: Innocan Pharma s CBD-Loaded Liposome Platform Technology Demonstrates a Prolonged Release of CBD in Large Animals

Innocan Pharma Corporation: Innocan Pharma s CBD-Loaded Liposome Platform Technology Demonstrates a Prolonged Release of CBD in Large Animals
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

IRW-News: InnoCan Pharma Corporation: Die mit CBD beladene Liposomenplattform-Technologie von Innocan Pharma zeigt eine verlängerte Freisetzung bei Großtieren

IRW-News: InnoCan Pharma Corporation: Die mit CBD beladene Liposomenplattform-Technologie von Innocan Pharma zeigt eine verlängerte Freisetzung bei Großtieren
boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.

Innocan Pharma Corporation: Innocan Pharma Updates its Progress in the Pre-Clinical Studies of its CBD-Loaded Liposome Platform (LPT)

(3) Herzliya, Israel and Calgary, Alberta (Newsfile Corp. - August 3, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the Company or Innocan ), is pleased to issue an update on its cutting-edge pre-clinical studies and on the development progress of its Liposome/CBD delivery platform (LPT). These studies are led by Dr. Ahuva Cern and Prof. Chezy Barenholz of The Hebrew University of Jerusalem. To date, Innocan completed two pre-clinical trials on animals. The first trial demonstrated no side effects, while the duration of a single intra-muscular injection resulted in the presence of a high level of CBD for at least 3 weeks in the plasma. In the second trial, the researchers observed the effect of CBD in a disease model of the central nervous system, while CBD was detected for a period of over 7 weeks, after 2 injections.

Lead Article: Will Arthrex Increase the Rare Involvement of the USPTO Director in Inter Partes Reviews? | Quinn Emanuel Urquhart & Sullivan, LLP

Lead Article: Will Arthrex Increase the Rare Involvement of the USPTO Director in Inter Partes Reviews? | Quinn Emanuel Urquhart & Sullivan, LLP
jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.